استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

Weight loss drug Mounjaro debuts, rivals in hot pursuit

March 21, 2025

|

Mint Mumbai

US company is pricing the anti-obesity treatment from ₹14,000 to ₹17,500 a month in India

- Jessica Jani

Weight loss drug Mounjaro debuts, rivals in hot pursuit

S drugmaker Eli Lilly & Co. brought its anti-obesity drug Mounjaro to India on Thursday, marking the country's first treatment of its kind, with monthly costs ranging from ₹14,000 to ₹17,500. The new drug, however, will face competition soon enough, with other foreign pharmaceutical companies planning to introduce similar products in a growing market.

Mounjaro's 2.5mg and 5mg vials will be priced at ₹3,500 and ₹4,375 respectively, in India. The injectable drug, used to treat obesity and type-2 diabetes, is to be taken once a week. The company had previously stated that it would price the drug, which costs around $1,000 per month ($86,315) in the US, competitively in India. "This India-specific pricing reflects Lilly's commitment to expanding access to innovative treatments in the country," the company said on Thursday.

المزيد من القصص من Mint Mumbai

Mint Mumbai

Mint Mumbai

Paint firms strengthen moats as competition heats up

A bruising market-share battle is escalating in India's ₹70,000-crore paints sector, forcing companies to look beyond aggressive discounting and instead strengthen their foothold in key geographical areas while sharpening their product portfolios.

time to read

2 mins

November 28, 2025

Mint Mumbai

Mint Mumbai

Telcos slam Trai penalty plan for financial report flaws

Trai has proposed turnover-linked penalties for filing incorrect, incomplete financial reports

time to read

2 mins

November 28, 2025

Mint Mumbai

Consumers warm up to Bolt as it aces 10-min hunger games

A year after launch, Bolt is emerging as Swiggy's fastest-scaling bet.

time to read

2 mins

November 28, 2025

Mint Mumbai

Doing India’s needy a good turn: Everyone is welcome to pitch in

What may seem weakly linked with positive outcomes on the ground could work wonders over time

time to read

3 mins

November 28, 2025

Mint Mumbai

Mint Mumbai

GOING SOLO: FACING THE GROWING REALITY OF SOLITARY RETIREMENT IN INDIA

What we plan for ourselves isn't always what life plans for us.

time to read

2 mins

November 28, 2025

Mint Mumbai

Mint Mumbai

Catamaran to boost manufacturing bets

Catamaran is focused on a few areas in manufacturing, such as aerospace

time to read

2 mins

November 28, 2025

Mint Mumbai

How the latest labour codes will benefit most employees

Workers may see an increase in some statutory benefits such as gratuity and leave encashment

time to read

4 mins

November 28, 2025

Mint Mumbai

Tune into weak signals in a world of data dominance

World War II saw the full fury of air power in battle, first exercised by Axis forces and then by the Allies, culminating in American B-29 bombers dropping atomic bombs on Hiroshima and Nagasaki.

time to read

4 mins

November 28, 2025

Mint Mumbai

Investors expect AI use to soar. That's not happening

An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.

time to read

2 mins

November 28, 2025

Mint Mumbai

Mint Mumbai

Tech startups on M&A route to boost scale, market share

M&As were earlier used to enter new markets or geographies, but that strategy has evolved

time to read

2 mins

November 28, 2025

Listen

Translate

Share

-
+

Change font size